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Abstract
Introduction: Both transposition of the great arteries (TGA) previously submitted to a Senning/
Mustard procedure and congenitally corrected TGA (cc-TGA) have the systemic circulation
supported by themorphological right ventricle, thereby rendering these patients to heart failure
events risk. The aim of this study was to evaluate cardiopulmonary exercise test parameters for
stratifying the risk of heart failure events in TGA patients.Methods: Retrospective evaluation of
adult TGA patients with systemic circulation supported by the morphological right ventricle
submitted to cardiopulmonary exercise test in a tertiary centre. Patients were followed up
for at least 1 year for the primary endpoint of cardiac death or heart failure hospitalisation.
Several cardiopulmonary exercise test parameters were analysed as potential predictors of
the combined endpoint and their predictive power were compared (area under the curve).
Results: Cardiopulmonary exercise test was performed in 44 TGA patients (8 cc-TGA), with
a mean age of 35.1 ± 8.4 years. The primary endpoint was reached by 10 (22.7%) patients, with
a mean follow-up of 36.7 ± 26.8 months. Heart rate at anaerobic threshold had the highest area
under the curve value (0.864), followed by peak oxygen consumption (pVO2) (0.838). Heart rate
at anaerobic threshold ≤95 bpm and pVO2 ≤20 ml/kg/min had a sensitivity of 87.5 and 80.0%
and a specificity of 82.4 and 76.5%, respectively, for the primary outcome. Conclusion: Heart
rate at anaerobic threshold ≤95 bpm had the highest predictive power of all cardiopulmonary
exercise test parameters analysed for heart failure events in TGA patients with systemic
circulation supported by the morphological right ventricle.
Transposition of the great arteries (TGA) is a CHD with an incidence of 0.02% per birth,1 while
congenitally corrected TGA (cc-TGA) has a lower incidence of 0.003% per birth.2 Until the
1980s, the Senning andMustard procedures were commonly performed for atrial switch, leaving
a systemic right ventricular prone to dysfunction. From the late 1980s and early 1990s onwards,
TGA has been managed instead by arterial switch operations in which the ventriculoarterial
discordance is rectified.3 Patients with uncorrected cc-TGA also have the systemic circulation
supported by the morphological right ventricle, thereby rendering these patients to an increased
risk for heart failure events.4
Several theories have been postulated for the progressive dysfunction of the systemic right
ventricle, which include the solely longitudinal arrangement of the cardiomyocytes in the right
ventricle versus the predominantly circumferential with the radial and longitudinal patterns of
the left ventricle,5 an increase in myocardial fibrosis due to right ventricle pressure overload and
hypertrophy6 and a decrease in coronary flow reserve.7–9
Failure of the systemic right ventricle could be resolved by anatomic repair either in Senning
andMustard patients (conversion to switch operation) or in cc-TGA (double-switch operation).
However, right ventricle dysfunction usually remains sub-clinical for decades and typically
manifests during fourth and fifth decades of life, when surgery is no longer a successful option,
leaving heart transplantation as the only long-term solution.10
The cardiopulmonary exercise test is a powerful predictor of mortality in heart failure
patients and is used as the standard criterion for the need for heart transplantation,11 with peak
oxygen consumption (pVO2) and the relation between ventilation and CO2 production (VE/
VCO2 slope) as the most used risk assessment tools.12 Several cardiopulmonary exercise test
studies had previously shown that adult CHD patients have reduced exercise capacity similar
to non-congenital heart failure patients13–15 and that cardiopulmonary exercise test can be used
to stratify the risk of heart failure events in adults with CHD similar to the heart failure patients.
In the Diller study,13 CHD patients with a pVO2 lower than 15.5 ml/kg/min had a 2-year event
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rate of 50% regarding death or heart failure hospitalisation,
whereas those with a pVO2 superior to 27 ml/kg/min had a 2-year
event rate of only 3%.
The aim of this study was to evaluate several cardiopulmonary
exercise test parameters for stratifying the risk of heart failure
events in TGA or cc-TGA patients with systemic right ventricle.
We hypothesised that cardiopulmonary exercise test parameters
may provide optimal prognostic information on midterm heart
failure events in this population.
To the best of our knowledge, this is the first study to address
the use of cardiopulmonary exercise test to stratify the risk of heart
failure events in solely TGA or cc-TGA patients with systemic right
ventricle without mixing other CHD and is one of the first studies
to compare several different cardiopulmonary exercise test param-
eters in only one type of adult CHD.
Methods
The investigation conforms to the principles outlined in the
Declaration of Helsinki. The institutional ethics committee
approved the study protocol and all patients provided consent
for the use of the collected information.
Patient population and study protocol
The study included a single tertiary centre retrospective analysis of
44 consecutive adult TGA patients with systemic circulation sup-
ported by the morphological right ventricle (TGA patients with
Senning or Mustard procedure and cc-TGA patients), referred
for cardiopulmonary exercise test as part of their clinical evaluation
between January 2010 and December 2017. Cardiopulmonary
exercise test is requested in our TGA patients with systemic right
ventricle at intervals from 3 to 5 years, even in asymptomatic
patients to detect early changes in exercise capacity. If one patient
performedmore than one cardiopulmonary exercise test during the
time of evaluation, the last one was used for the analysis. Clinical,
laboratorial, and echocardiographic information were also collected
at the time of cardiopulmonary exercise test when available.
Patients were considered cyanotic if they had an oxygen satu-
ration lower than 90% at rest.
Follow-up and endpoint
In order to stratify the risk of heart failure events in TGA patients
using cardiopulmonary exercise test parameters, all patients were
followed up for at least 12 months from the date of completion of
the cardiopulmonary exercise test. The primary endpoint was a
composite of cardiac death or heart failure hospitalisation. Data
were obtained from the outpatient clinic visits and medical charts
review and were complemented with a standardised telephone
interview to all patients at the end of follow-up. Information
regarding all-cause mortality and hospitalisation for other cardiac
reasons were also gathered.
Cardiopulmonary exercise test
A maximal symptom-limited treadmill cardiopulmonary exercise
test was performed using the modified Bruce protocol (GE
Marquette Series 2000 treadmill, Marquette Medical Systems,
Inc., Milwaukee, WI, United States of America). Gas analysis
was preceded by calibration of the equipment. Minute ventilation,
oxygen uptake, and carbon dioxide production were acquired
breath-by-breath, using a SensorMedics Vmax 229 gas analyser
(SensorMedics Corporation, Yorba Linda, CA, United States of
America). Patients were encouraged to perform exercise until
the respiratory exchange ratio was ≥1.10.
Heart rate was measured by continuous electrocardiogram,
blood pressure was obtainedmanually with a sphygmomanometer,
and oxygen saturation was monitored by pulse oximetry. Standard
spirometry was not available in all patients.
Cardiopulmonary exercise test parameters
The pVO2 was defined as the highest 30-second average achieved
during exercise and was normalised for body mass. Percentage
predicted pVO2 (pVO2 predicted (%)) was calculated from the
Wasserman equations.16 The VE/VCO2 slope was calculated by
least squares linear regression, using data acquired throughout
the whole exercise.17
The cardiorespiratory optimal point of ventilation was
measured as the minimum value of the ventilatory equivalent
for oxygen (VE/VO2 minimum), corresponding to the moment
during the incremental exercise in which there is less ventilation
for a litre of oxygen to be consumed.18
The anaerobic threshold was determined by combining the
standard methods (V-slope preferentially and ventilatory
equivalents).19
Partial pressure of end-tidal carbon dioxide (PETCO2) was
reported before exercise, at anaerobic threshold and at peak
exercise in mmHg units.20 Since the increase during exercise
until the anaerobic threshold is achieved (PETCO2 at anaerobic
threshold – PETCO2 at rest) has prognostic importance in heart
failure patients, this parameter was also calculated.16
Heart rate reserve was calculated as the difference between the
maximal heart rate achieved with exercise and the resting heart
rate.21 Heart rate recovery in the first minute after exercise was
defined as the difference between the maximal heart rate achieved
with exercise and the heart rate 1 minute into recovery.16
Chronotropic incompetence patients were defined as those with
a peak heart rate at exercise lower than 80% of the estimated maxi-
mal heart rate (220 – age), or lower than 62% of the estimated
maximal heart rate if the patients were prescribed with negative
chronotropic agents.22
Statistical analysis
Baseline characteristics were summarised as frequencies (percent-
ages) for categorical variables, as means and standard deviations
for continuous variables when normality was verified, and as
median and interquartile range when normality was not verified
by the Kolmogorov–Smirnov test. The Student’s t-test for indepen-
dent samples or the Mann–Whitney test when normality was not
verified was used for the analysis of the variables.
Univariable Cox proportional hazards models were applied,
with p-values for time-to-event analyses being based on log-rank
tests, and hazard ratios for treatment effects and 95% confidence
intervals presented to study the combined endpoint considering
the follow-up time for the different cardiopulmonary exercise test
parameters.
The predictive power of several cardiopulmonary exercise test
parameters was analysed for the highest area under the curve in the
follow-up.23 Cut-off values for variables were determined from the
receiver operating characteristics curves so that the sum of sensi-
tivity and specificity was maximised.24 Hanley andMcNeil test was
used to compare two correlated receiver operating characteristics
curves.25
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Statistical differences with a p-value <0.05 were considered
significant.
Results
Overview of TGA patients
A total of 44 patients were enrolled in the study, 36 (81.8%) TGA
patients previously submitted to a Senning/Mustard procedure
and 8 (18.2%) cc-TGA patients. The baseline characteristics are
presented in Table 1.
The mean age was 35.1 ± 8.5 years, with a higher percentage of
males (72.7%) in the population. Regarding clinical data, the vast
majority of the population were in NYHA class I or II (29.5 and
47.7%, respectively), with eight (18.2%) cyanotic patients.
Medication with negative chronotropic agents was presented in
nine (20.5%) patients, all of them using beta-blockers. There were
only four patients treated with angiotensin-converting enzyme
inhibitor or angiotensin receptor blockers (9%). There were 11
patients (20%) on diuretic treatment.
A previous pacemaker implantation was performed with four
VVIR and three DDDR pacemaker’s systems in seven (15.9%)
patients. The four VVIR system carriers were the only patients
in atrial fibrillation during cardiopulmonary exercise test.
Other cardiac anomalies associated with TGA not fully
corrected at the time of the cardiopulmonary exercise test included
ventricular septal defects (29.5%), pulmonary stenosis (20.5%),
atrial septal defects (6.8%), and atrioventricular septal defect
(2.3%). Regarding previous surgeries, 25 (69.4%) and 11 (30.6%)
of the TGA patients had a Senning andMustard procedure, respec-
tively. In cc-TGA patients, only one had one previous surgery for
an atrioventricular septal defect correction.
Laboratorial data showed no patient with a glomerular filtration
rate lower than 30 ml/min as well as no patient with anaemia. Brain
natriuretic peptide values were highly variable between patients
(a median value of 68 (41–421) pg/ml).
With respect to echocardiographic data, tricuspid annular
plane systolic excursion was lower than 16 mm in 26 (68.4%)
patients, with 9 (20.5%) patients with at least moderate A-V
systemic regurgitation and no patient with sub-pulmonary ventricle
dysfunction.
Primary outcome
All patients were followed up for at least 12 months from the date
of completion of the cardiopulmonary exercise test, with a mean
± standard deviation follow-up time of 36.7 ± 26.8 months. The
primary endpoint, a composite of cardiac death or heart failure
hospitalisation, occurred in 10 (22.7%) patients (one death
and nine heart failure hospitalisations). No patient was lost to
follow-up.
Relationship between cardiopulmonary exercise test
parameters and primary outcome
A maximal symptom-limited treadmill cardiopulmonary exercise
test was performed using the modified Bruce protocol in all
patients, revealing a pVO2 predicted (%) lower than 50% in
16 (36.3%) patients. Anaerobic threshold was achieved by
42 (95.5%) patients, but the respiratory exchange ratio was lower
than 1.05 and 1.10 in 40.9 and 59.1%, respectively, despite patients
were encouraged to perform exercise until the respiratory
exchange ratio ≥1.10. There were no complications during the
cardiopulmonary exercise test exam, and the patients finished
exercising because of fatigue (59.1%) or dyspnea (40.9%).
Chronotropic incompetence was presented in 24 (54.5%) patients.
The univariate predictors of the primary outcome by cardio-
pulmonary exercise test parameters are represented in Table 2,
showing that pVO2, pVO2 (%) predicted, VE/VCO2 slope,
PETCO2 at peak exercise, heart rate at anaerobic threshold, time
until anaerobic threshold, VO2 at anaerobic threshold, HHR, O2
saturation at peak, and chronotropic index were all predictors of
the primary outcome (p < 0.05 for all).
Only cardiorespiratory optimal point, heart rate recovery in the
first minute after exercise, and the difference between PETCO2 at
Table 1. Baseline characteristics.
n= 44
Age (years) 35.1 ± 8.5
Male (%) 32 (72.7%)
Body mass index (kg/m2) 24.8 ± 3.8
NYHA ≥ III 10 (22.8%)
TGA after Senning/Mustard procedure (%) 36 (81.8%)
cc-TGA (%) 8 (18.2%)
Pulmonary hypertension (%) 12 (27.3%)
Cyanotic patients (%) 8 (18.2%)
Sinus rhythm (%) 40 (90.9%)
Negative chronotropic agents 9 (20.5%)
Pacemaker 7 (15.9%)
Tricuspid annular plane systolic excursion (mm) 14.6 ± 2.8
At least moderate atrioventricular systemic regurgitation 9 (20.5%)
Hemoglobin (g/dL) 15.7 ± 2.2
Creatinine (mg/dL) 0.8 ± 0.2
Sodium (mEq/L) 139.0 ± 2.8
Median BNP (pg/ml) and interquartile range 68 (41–421)
Cardiopulmonary exercise test data
pVO2 (ml/kg/min) 22.9 ± 6.5
pVO2 predicted (%) 55.8 ± 13.4
VE/VCO2 slope 35.7 ± 9.3
Cardiorespiratory optimal point 26.5 ± 5.5
Duration at anaerobic threshold (seconds) 499.8 ± 234.2
VO2 at anaerobic threshold (ml/kg/min) 16.4 ± 5.8
Heart rate at anaerobic threshold (bpm) 114.5 ± 25.5
PETCO2 at anaerobic threshold – initial PETCO2 3.7 ± 5.2
Heart rate reserve (bpm) 71.7 ± 31.4
Heart rate recovery in the first minute after exercise (bpm) 21.9 ± 15.9
Chronotropic incompetence (%) 22 (50.0%)
Respiratory exchange ratio 1.1 ± 0.1
O2 saturation at rest (%) 93.9 ± 3.2
O2 saturation at peak exercise (%) 85.0 ± 10.5
cc-TGA= corrected transposition of the great arteries; TGA= transposition of the great arteries;
BNP= brain natriuretic peptide; VE= ventilation.
Values are mean ± standard deviation (normal distribution in all characteristics).
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anaerobic threshold and rest did not achieve significant statistical
difference (p between 0.05 and 0.10).
In addition to the Cox analysis, these cardiopulmonary exercise
test parameters were analysed for the highest area under the curve
in the follow-up period (Table 3).
Heart rate at anaerobic threshold had the highest area under the
curve value (0.864), followed by pVO2 (0.838) and O2 saturation at
peak exercise (0.830). With the exception of heart rate recovery in
the firstt minute after exercise (0.675), all parameters analysed had
an area under the curve value higher than 0.700.
Since four (9.1%) patients were in atrial fibrillation, a sub-
analysis was performed only with patients in sinus rhythm without
an increase in the area under the curve value of heart rate at anaerobic
threshold (0.853).
Since pVO2 prognosis power had been related to the need to per-
form a trulymaximum cardiopulmonary exercise test, as assessed by
a respiratory exchange ratio >1.05,20 a sub-analysis was performed
showing an area under the curve value of 0.829 (CI 0.608–1.000) in
patients with a respiratory exchange ratio >1.05.
Another sub-analysis was performed regarding VE/VCO2 slope
excluding cyanotic patients, since previous studies have shown a
lack of correlation between VE/VCO2 slope and prognosis in
this group of patients,26,27 without a significant decrease in the
AUC value.
Cut-off values for variables were determined from the ROC
curves so that the sum of sensitivity and specificity was maximised
and are presented in Table 4.
Reaching anaerobic threshold before the 7 minute of exercise
and a VO2 at anaerobic threshold ≤15 ml/kg/min had a sensitivity
of 87.5% and a specificity of 83.5% for the primary outcome. The
most used cardiopulmonary exercise test parameters regarding
prognosis in heart failure had a sensitivity of 80.0 and 87.5%
and a specificity of 76.5 and 67.6%, respectively, for pVO2
≤20 ml/kg/min and VE/VCO2 slope >37.0, slightly lower than
the values achieved with anaerobic threshold time, heart rate
at anaerobic threshold, and VO2 at anaerobic threshold. No
differences were found in the analysis excluding atrial fibrillation
patients.
The Hanley and McNeil test was applied for comparing each
area under the curve parameters, with no statistically significant
difference found.
Discussion
In a group of adult TGA patients with systemic circulation sup-
ported by the morphological right ventricle and evidence of limi-
tation in their exercise capacity, as shown by baseline mean values
of pVO2 predicted (%) of 55.8 ± 13.4%, several cardiopulmonary
exercise test parameters were predictors of the primary outcome
of cardiac death or heart failure hospitalisation, including pVO2,
pVO2 (%) predicted, VE/VCO2 slope, PETCO2 at peak exercise,
heart rate at anaerobic threshold, time until anaerobic threshold,
VO2 at anaerobic threshold, heart rate reserve, O2 saturation at







pVO2 10.143 0.787 0.001 0.678–0.912
pVO2 predicted (%) 5.442 0.935 0.020 0.884–0.989
VE/VCO2 slope 6.606 1.086 0.010 1.020–1.157
Optimal point of ventilation 2.837 1.090 0.092 0.986–1.205
End-tidal CO2 at AT – at rest 2.897 0.903 0.089 0.803–1.016
End-tidal CO2 at peak 4.603 0.893 0.032 0.805–0.990
AT time 8.530 0.994 0.003 0.991–0.998
HR at AT 8.645 0.947 0.003 0.913–0.982
VO2 at AT 10.218 0.736 0.001 0.610–0.888
HR reserve 8.533 0.976 0.003 0.960–0.992
HR recovery in the first minute
after exercise
3.738 0.929 0.053 0.863–1.001
O2 saturation at peak 11.131 0.958 0.001 0.934–0.982
Chronotropic index 10.965 0.958 0.001 0.935–0.983
AT= anaerobic threshold; HR = heart rate; VE= ventilation.
Table 3. AUC analysis.




pVO2 predicted (%) 0.749 0.554–0.994
VE/VCO2 slope 0.713 0.506–0.921
Optimal point of ventilation 0.729 0.554–0.903
End-tidal CO2 at anaerobic threshold – at rest 0.769 0.585–0.953
End-tidal CO2 at peak 0.745 0.584–0.906
Anaerobic threshold time 0.818 0.630–1.000
Heart rate at anaerobic threshold 0.864 0.716–1.000
VO2 at anaerobic threshold 0.807 0.627–0.987
Heart rate reserve 0.779 0.623–0.936
Heart rate recovery in the first minute after
exercise
0.675 0.460–0.890
O2 saturation at peak 0.830 0.700–0.959
Chronotropic index 0.802 0.649–0.955
AUC= area under the curve; VE= ventilation.









pVO2 (ml/kg/min) <20.0 80.0 76.5
pVO2 predicted (%) <50% 70.0 67.6
VE/VCO2 slope >37.0 87.5 67.6
Optimal point of ventilation >28.0 77.8 73.5
End-tidal CO2 at AT2 – at rest (mmHg) <1.8 71.4 73.5
AT2 time (min) <7 87.5 83.5
Heart rate at AT2 (bpm) <95 87.5 82.4
VO2 at AT2 (ml/kg/min) <15.0 87.5 83.5
Heart rate reserve (bpm) <70 70.0 76.5
O2 saturation at peak (%) <86% 88.9 69.0
Chronotropic index (%) <78% 88.9 62.5
AT= anaerobic threshold; VE= ventilation.
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peak, and chronotropic index (all with a p< 0.05), while cardio-
respiratory optimal point, heart rate recovery in the first minute
after exercise, and the difference between PETCO2 at anaerobic
threshold and rest did not achieve statistical significance
(p between 0.05 and 0.10).
In heart failure patients, cardiopulmonary exercise test is a
powerful predictor of mortality and is used as the standard cri-
terion for the need for heart transplantation,11 with pVO2 and
VE/VCO2 slope as the most used risk assessment tools.12 Several
trials had tried a similar approach to predict survival in CHD
patients, showing that pVO2 and VE/VCO2 slope are related to
midterm survival in this patients.13,14
In a previous investigation, VE/VCO2 slope was the most
powerful exercise predictor of mortality on non-cyanotic adult
CHD patients.26 However, some studies had not shown the
same prognostic prediction with VE/VCO2 slope in cyanotic
patients,14,26,27 suggesting that cyanosis is associated with raised
VE/VCO2 slope, but these higher values should not be extrapolated
alone to predict a worse prognosis. In our study, despite being a
univariate predictor of the primary outcome (p= 0.010), VE/
VCO2 slope only achieved an area under the curve value of
0.713, numerically lower than other analysed parameters like
pVO2 (0.838) and heart rate at anaerobic threshold (0.864).
Since 18.2% of the patients were cyanotic, a sub-analysis was
performed in non-cyanotic patients, without an increase in the
area under the curve value (0.703).
Of all the parameters analysed, pVO2 had the second highest
area under the curve value (0.838), with a value lower than
20 ml/kg/min achieving a sensitivity of 80.0% and a specificity
of 76.5% for the primary outcome. As well as other cardio-
pulmonary exercise test parameters, pVO2 had been related to
the need to perform a truly maximum cardiopulmonary exercise
test, as assessed by a respiratory exchange ratio > 1.05.20
However, in our population, respiratory exchange ratio was lower
than 1.05 in 40.9%, so we performed a sub-analysis for pVO2 in
patients with respiratory exchange ratio > 1.05 which showed
an area under the curve value of 0.829, numerically lower than
the 0.838 achieved with all patients.
Anaerobic threshold represents the moment where anaerobic
metabolism becomes relevant for the production of the amount
of energy demanded by exercise.19 Previous studies in CHD
patients have shown that VO2 at anaerobic threshold values is
below normal (45–65% of the pVO2),28 and some may fail to
achieve anaerobic threshold in a way similar to heart failure
patients.29 In our trial, VO2 at anaerobic threshold values was
55.8 ± 13.4% of the pVO2, and only two (4.5%) patients failed to
achieve anaerobic threshold, a lower percentage than previous
trials with all types of CHD.
Parameters related to anaerobic threshold (anaerobic threshold
time < 7 minute of exercise, heart rate at anaerobic threshold
< 95 bpm, and VO2 at anaerobic threshold <15.0 ml/kg/min)
reached the highest values of sensitivity (87.5%) and specificity
(82.4–83.5%) for the prediction of the primary outcome,
suggesting that they should be used in the routine evaluation of
these patients to stratify the risk of cardiac death or heart failure
hospitalisation.
Chronotropic incompetence was previously related tomortality
in adult CHD patients21 and is common in this group patients
(30–60% of the patients27), since they usually have a blunted heart
response to exercise related to autonomic dysfunction, cardiac
arrhythmias, and high use of chronotropic negative medication,
like beta-blockers.21,30 However, some trials have shown that
beta-blockers have beneficial effects in systemic right ventricular
dysfunction,31,32 being the medication with the most supportive
data for TGA patients with systemic right ventricle dysfunction.
Medication with beta-blockers was presented in nine (20.5%)
patients, which may be explained by a mean tricuspid annular
plane systolic excursion of 14.6 ± 2.8 mm, and there was no
relationship regarding the use of beta-blockers to the primary
outcome. Additionally, a previous pacemaker implantation was
performed in seven (15.9%) patients; however, all of them had a
rate responsive function.
In our study, chronotropic incompetence was present in
24 (54.4%) patients, with a mean chronotropic index of
72.0 ± 20.6%. Chronotropic index had an area under the curve
value of 0.802, with a value lower than 78% with high sensitivity
(88.9%) but lower specificity (62.5%) for the primary outcome.
Other heart rate-related parameters (heart rate reserve; heart
rate recovery in the first minute after exercise) had shown prognos-
tic importance in CHD patients.14,15 In our trial, heart rate reserve
as opposed to heart rate recovery in the first minute after exercise
was a significant predictor of the primary outcome (p= 0.003
versus p= 0.053). Other parameters had higher values of sensitivity
and specificity than heart rate reserve and heart rate recovery in the
first minute after exercise, which could be explained by the
confound effect of patients doing beta-blockers and with previous
pacemaker implantation. Few patients (9.1%) were in atrial
fibrillation.
Despite a previous trial showing that cardiorespiratory optimal
point is a good predictor of all-cause mortality in adults,33 in our
trial cardiorespiratory optimal point did not achieve statistical sig-
nificance for the prediction of the outcome (p = 0.092). Likewise,
the increase in PETCO2 until the anaerobic threshold is achieved
(PETCO2 at anaerobic threshold – PETCO2 at rest), which was
previously shown to have prognostic importance in heart failure
patients16 did not achieve statistical significance neither (p= 0.089).
To the best of our knowledge, this was the first time that cardio-
respiratory optimal point was assessed in a CHD population.
Uncertainty remains about managing systemic right ventricular
failure8 and heart transplantation currently remains the only long-
term life-saving procedure.4 Despite a number of confounders that
are less relevant in heart failure, cardiopulmonary exercise test was
able to predict heart failure events in this TGA population with sys-
temic right ventricle. These confounders include a high number of
patients with a respiratory exchange ratio lower than 1.05 (40.9%),
which may favour the use of sub-maximal exercise parameters such
as VO2 at anaerobic threshold rather than maximal effort-dependent
parameters such as pVO2. However, when the Hanley and
McNeil test was applied for comparing each area under the curve
parameters, no statistically significant difference was found, which
is not surprising since previous studies have already shown that
the usual benchmarks for interpretation of respiratory exchange
ratio may not have the same meaning in patients with CHD.34
Study limitations
There are limitations to our study that should be referred when
interpreting our results. This was a single-centre retrospective
experience with only 44 patients, and therefore, the results can
reflect local practice and might not represent other adult CHD
centres. Despite being a small study, to the best of our knowledge,
it is the first study addressing the use of cardiopulmonary exercise
test to stratify the risk of heart failure events in TGA patients with
systemic right ventricle alone without mixing other CHD and
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showed promising results for the use of cardiopulmonary exercise
test to predict heart failure events in this population.
Mustard/Senning physiology and response to exercise may not
be completely similar to cc-TGA patients despite having a systemic
right ventricle, since atrial baffles cause a relative preload reduction
during exercise when compared to cc-TGA patients.35 However,
the results would be similar if we only analysed the 36 atrial switch
operation patients.
The primary outcome was a composite of cardiac death and
heart failure hospitalisation. Although heart failure hospitalisation
is not as important as cardiac death for the prognosis of the
patients, heart failure hospitalisation is a major hazard for adult
CHD patients and is associated with substantial costs and an
amplified risk of subsequent mortality,13,36,37 so we used it to
increase the percentage of the primary outcome since cardiac mor-
tality was low in the mean 3-year follow-up (2.3%).
Each cardiopulmonary exercise test parameter was analysed for
the area under the curve and the cut-off value so that the sum of
sensitivity and specificity was maximised. However, some interac-
tion between cardiopulmonary exercise test parameters cannot be
excluded, and the results cannot be interpreted as if each cardio-
pulmonary exercise test parameter has a prognosis power that can
be added to the predictive power of other cardiopulmonary exer-
cise test parameters.
Several cardiopulmonary exercise test parameters had been
related to the need to perform a truly maximum cardiopulmonary
exercise test, as assessed by a respiratory exchange ratio >1.05.20
However, in our population, the respiratory exchange ratio was
lower to 1.05 in 40.9%, so we decided to perform a sub-analysis
for pVO2 in patients with a respiratory exchange ratio>1.05 which
showed an area under the curve value of 0.829, no higher than the
0.838 achieved with all patients. Additionally, we used several
parameters (VE/VCO2 slope, cardiorespiratory optimal point,
and PETCO2 at anaerobic threshold – PETCO2 at rest) that do
not need a maximal exercise cardiopulmonary exercise test to have
prognostic power.16
In a similar way, another sub-analysis was performed regarding
VE/VCO2 slope excluding cyanotic patients, since previous studies
have shown a lack of correlation between VE/VCO2 slope and
prognosis in this group of patients,26,27 with an area under the curve
value of 0.703, no higher than the 0.713 achieved with all patients.
Conclusions
Patients with both TGA previously submitted to a Senning/
Mustard procedure and cc-TGA have right ventricle working
against systemic pressures, thereby rendering these patients to
an increased risk for heart failure events. Heart rate at anaerobic
threshold had the highest predictive power of all cardiopulmonary
exercise test parameters analysed, with a value ≤95 bpm achieving
a sensitivity of 87.5% and a specificity of 82.4% for the primary out-
come. Additionally, in a way similar to heart failure patients, several
cardiopulmonary exercise test parameters were able to provide prog-
nostic information regarding heart failure events, suggesting that
cardiopulmonary exercise test should be used in the routine evalu-
ation of these patients as a prognostic tool.
Acknowledgements. We sincerely thank Centro Hospitalar Universitário
Lisboa Central for the opportunity to perform this study.
Financial Support. This research received no specific grant from any funding
agency, commercial, or not-for-profit sectors.
Conflicts of Interest. None
References
1. Villafane J, Lantin-Hermoso MR, Bhatt AB, et al. D-transposition of the
great arteries: the current era of the arterial switch operation. J Am Coll
Cardiol 2014; 64: 498–511.
2. Wallis GA, Debich-Spicer D, Anderson RH. Congenitally corrected trans-
position. Orphanet J Rare Dis 2011; 6: 22.
3. Shah S, Gupta T, Ahmad R. Managing heart failure in transposition of the
great arteries. Ochsner J 2015; 15: 290–296.
4. Filippov AA, Del Nido PJ, Vasilyev NV. Management of systemic right
ventricular failure in patients with congenitally corrected transposition
of the great arteries. Circulation 2016; 134: 1293–1302.
5. Lopez L, Cohen MS, Anderson RH, et al. Unnatural history of the right
ventricle in patients with congenitally malformed hearts. Cardiol Young
2010; 20 (Suppl 3): 107–112.
6. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium.
Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83:
1849–1865.
7. Hauser M, Bengel FM, Hager A, et al. Impaired myocardial blood flow and
coronary flow reserve of the anatomical right systemic ventricle in patients
with congenitally corrected transposition of the great arteries. Heart 2003;
89: 1231–1235.
8. Winter MM, Bouma BJ, Groenink M, et al. Latest insights in therapeutic
options for systemic right ventricular failure: a comparison with left ven-
tricular failure. Heart 2009; 95: 960–963.
9. Hauser M, Meierhofer C, Schwaiger M, Vogt M, Kaemmerer H, Kuehn A.
Myocardial blood flow in patients with transposition of the great arteries –
risk factor for dysfunction of the morphologic systemic right ventricle late
after atrial repair. Circ J 2015; 79: 425–431.
10. Said SM, Burkhart HM, Schaff HV, Dearani JA. Congenitally corrected
transposition of great arteries: surgical options for the failing right ventricle
and/or severe tricuspid regurgitation. World J Pediatr Congenital Heart
Surg 2011; 2: 64–79.
11. Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society
for Heart Lung Transplantation listing criteria for heart transplantation:
a 10-year update. J Heart Lung Transplant 2016; 35: 1–23.
12. Butler J, KhadimG, Paul KM, et al. Selection of patients for heart transplan-
tation in the current era of heart failure therapy. J AmColl Cardiol 2004; 43:
787–793.
13. Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult
congenital heart disease: comparative severity, correlates, and prognostic
implication. Circulation 2005; 112: 828–835.
14. Inuzuka R,Diller GP, Borgia F, et al. Comprehensive use of cardiopulmonary
exercise testing identifies adults with congenital heart disease at increased
mortality risk in the medium term. Circulation 2012; 125: 250–259.
15. Mantegazza V, Apostolo A, Hager A. Cardiopulmonary exercise testing in
adult congenital heart disease. Ann Am Thorac Soc 2017; 14 (Suppl 1):
S93–S101.
16. Guazzi M, Arena R, Halle M, Piepoli MF, Myers J, Lavie CJ. 2016 Focused
update: clinical recommendations for cardiopulmonary exercise testing
data assessment in specific patient populations. Circulation 2016; 133:
e694–e711.
17. Clark AL, Poole-Wilson PA, Coats AJ. Relation between ventilation and
carbon dioxide production in patients with chronic heart failure. J Am
Coll Cardiol 1992; 20: 1326–1332.
18. Ramos PS, RicardoDR, Araujo CG. Cardiorespiratory optimal point: a sub-
maximal variable of the cardiopulmonary exercise testing. Arq Bras Cardiol
2012; 99: 988–996.
19. Wasserman K, Stringer WW, Casaburi R, Koike A, Cooper CB.
Determination of the anaerobic threshold by gas exchange: biochemical
considerations, methodology and physiological effects. Z Kardiol 1994;
83 (Suppl 3): 1–12.
20. Balady GJ, Arena R, Sietsema K, et al. Clinician’s guide to cardiopulmonary
exercise testing in adults: a scientific statement from the American Heart
Association. Circulation 2010; 122: 191–225.
6 A. V. Gonçalves et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1047951119002361
Downloaded from https://www.cambridge.org/core. University of Massachusetts Amherst, on 20 Oct 2019 at 15:30:22, subject to the Cambridge Core terms of use, available at
21. Diller GP, Dimopoulos K, Okonko D, et al. Heart rate response during
exercise predicts survival in adults with congenital heart disease. J Am
Coll Cardiol 2006; 48: 1250–1256.
22. Khan MN, Pothier CE, Lauer MS. Chronotropic incompetence as a
predictor of death among patients with normal electrograms taking
beta blockers (metoprolol or atenolol). Am J Cardiol 2005; 96:
1328–1333.
23. Heagerty PJ, Lumley T, PepeMS. Time-dependent ROC curves for censored
survival data and a diagnostic marker. Biometrics 2000; 56: 337–344.
24. Bewick V, Cheek L, Ball J. Statistics review 13: receiver operating character-
istic curves. Crit Care 2004; 8: 508–512.
25. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver
operating characteristic (ROC) curve. Radiology 1982; 143: 29–36.
26. Dimopoulos K, Okonko DO, Diller GP, et al. Abnormal ventilatory
response to exercise in adults with congenital heart disease relates to
cyanosis and predicts survival. Circulation 2006; 113: 2796–2802.
27. Khan AM, Paridon SM, Kim YY. Cardiopulmonary exercise testing in
adults with congenital heart disease. Expert Rev Cardiovasc Ther 2014;
12: 863–872.
28. Reybrouck T, Rogers R,WeymansM, et al. Serial cardiorespiratory exercise
testing in patients with congenital heart disease. Eur J Pediatr 1995; 154:
801–806.
29. Kadish A, Nademanee K, Volosin K, et al. A randomized controlled trial
evaluating the safety and efficacy of cardiac contractility modulation in
advanced heart failure. Am Heart J 2011; 161: 329–337 e1-2.
30. Reybrouck T, Vangesselen S, Gewillig M. Impaired chronotropic response
to exercise in children with repaired cyanotic congenital heart disease. Acta
Cardiol 2009; 64: 723–727.
31. Bouallal R, Godart F, Francart C, Richard A, Foucher-Hossein C, Lions C.
Interest of beta-blockers in patients with right ventricular systemic dys-
function. Cardiol Young 2010; 20: 615–619.
32. DoughanAR,McConnellME, BookWM.Effect of beta blockers (carvedilol or
metoprolol XL) in patientswith transposition of great arteries and dysfunction
of the systemic right ventricle. Am J Cardiol 2007; 99: 704–706.
33. Ramos PS, Araujo CG. Cardiorespiratory optimal point during exercise
testing as a predictor of all-cause mortality. Rev Port Cardiol 2017; 36:
261–269.
34. Glaser S, Opitz CF, Bauer U, et al. Assessment of symptoms and exercise
capacity in cyanotic patients with congenital heart disease. Chest 2004; 125:
368–376.
35. Fratz S, Hager A, Busch R, et al. Patients after atrial switch operation for
transposition of the great arteries can not increase stroke volume under
dobutamine stress as opposed to patients with congenitally corrected trans-
position. Circ J 2008; 72: 1130–1135.
36. Moons P, Siebens K, De Geest S, Abraham I, Budts W, Gewillig M. A pilot
study of expenditures on, and utilization of resources in, health care in
adults with congenital heart disease. Cardiol Young 2001; 11: 301–313.
37. Kaemmerer H, Fratz S, Bauer U, et al. Emergency hospital admissions
and three-year survival of adults with and without cardiovascular surgery
for congenital cardiac disease. J Thorac Cardiovasc Surg 2003; 126: 1048–1052.
Cardiology in the Young 7
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1047951119002361
Downloaded from https://www.cambridge.org/core. University of Massachusetts Amherst, on 20 Oct 2019 at 15:30:22, subject to the Cambridge Core terms of use, available at
